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Do diurnal cortisol levels mediate the association between sleep disturbances 
and cognitive impairment? 
 
José Haba-Rubio, Sami Ouanes, Yannick Franc, Pedro Marques-Vidal, Gerard Waeber, Peter Vollenweider, Armin 
von Gunten, Martin Preisig, Christine Kuehner, Enrique Castelao, Raphaël Heinzer, Julius Popp 
 
a b s t r a c t 
Previous research found an association between sleep disturbances and cognitive deficits on the one hand, and 
between increased cortisol levels and poor cognitive performance on the other hand. We hypothesized that cortisol 
may, at least partially, mediate the link between sleep disturbances and cognitive impairment (CI). We analyzed 
data from 440 nondemented subjects aged _65 years (72.4 _ 4.5 years old, 55.7% women) participating at the 
population-based CoLaus/PsyCoLaus study, who underwent cognitive evaluation, complete polysomnography and 
cortisol measures during the day. Subjects with CI (N ¼ 207, 47.05% of the sample) had lower sleep efficiency, 
less deep sleep (stage N3) and rapid eye movement sleep, and higher apnea/hypopnea index and oxygen 
desaturation index. After adjustment for possible confounders, oxygen desaturation index (_4% and _6% per hour 
of sleep) were significantly associated with impaired cognitive performance. The results of Sobel’s test for mediation 
using the regressions between the sleep-related variables and cortisol values, and between the cortisol and the 
Clinical Dementia Rating score were not significant (all p > 0.05). Our data suggest that sleepdisordered breathing 
is associated with CI, but that this association is not mediated by increased diurnal cortisol levels. 
 
1. Introduction 
We have recently shown that elderly subjects from the general population with cognitive impairment (CI), compared 
with subjects with normal cognition, had significant differences in sleep patterns. 
These differences seem to be related to the occurrence of sleepdisordered breathing (SDB) (Haba-Rubio et al., 
2017). SDB is highly prevalent in the general population, affecting 23.4% of women and 49.7% of men, and this 
prevalence rises markedly with age (Heinzer et al., 2015). SDB induces intermittent hypoxemia, and it has been 
associated with high cortisol levels (Vgontzas et al., 2007). High levels of cortisol could also have neurotoxic effects 
(Byers and Yaffe, 2011), and several studies have shown an association between increased cortisol levels and 
poor cognitive performances (Ouanes et al., 2017; Popp et al., 2015). The aim of our study was thus to evaluate 
the potential mediating effect of cortisol between sleep disturbances and CI. 
 
2. Methods 
This study is based on the subsample of 440 nondemented (Clinical Dementia Rating [CDR] < 1) subjects aged 
_65 years who participated in the CoLaus/PsyCoLaus study (Firmann et al., 2008; Preisig et al., 2009), and who 
had a complete cognitive assessment, a polysomnography (PSG), and salivary cortisol measures comprehensive 
neuropsychological test battery (Ouanes et al., 2017) and overall cognitive and functional status was assessed 
using the CDR scale (Morris, 1993). Participants were divided into 2 groups: participants with CI (CDR > 0) and 
participants with normal cognition (CDR ¼ 0). Four salivary samples were obtained fromeach participant: on waking, 
30 minutes after waking, at 11 AM, and at 8 PM. The cortisol area under the curve was also calculated. Logistic 
regression models were constructed for sleep and cortisol variables according to CDR status, controlling for age, 
sex, alcohol and tobacco consumption, drugs influencing sleep, level of education, body mass index, metabolic 
syndrome, hypertension, diabetes, and depression, and Sobel’s test for mediation was performed using the 
regression between the sleep variables and the cortisol measures, and the regression between the cortisol and the 
CDR status. 
 
3. Results 
CI (CDR > 0) was present in 207 participants (47.05% of the sample, Table S2). Compared with participants with 
normal cognition, they had lower sleep efficiency, lower slow wave and rapid eyemovement sleep, and higher 
apnea/hypopnea index (AHI) and oxygen desaturation index (ODI). However, no significant differences were found 
for cortisol measures between groups, except a trend toward higher cortisol values at 11 AM (Table S3). For each 
PSG-derived variable and cortisol measure, binary logistic regression models were constructed and adjusted for 
age, sex, body mass index, alcohol and tobacco consumption, psychotropic drugs influencing sleep, level of 
education, and the presence of hypertension, diabetes, metabolic syndrome, and depression. In these models, only 
the ODI _ 4 (regression coefficient ß for an increase of 1 unit: 0.0047, 95% confidence interval [95% CI]: 
0.0002e0.0091, p = 0.037) and the ODI _ 6 (ß: 0.0075, 95% CI: 0.0010e0.0141, p = 0.023) remained significantly 
and independently associated with the presence of CI. 
The results of Sobel’s test for mediation using the regressions between either the AHI or the ODI and the cortisol 
measurements, and between cortisol and the CDR scorewere not significant (all p >0.05, Table S5). 
 
4. Discussion 
The main aim of this study was to evaluate increased cortisol levels as a potential pathway leading from sleep 
disturbances to CI. Subjects aged _65 years from the general population with CI had significant differences in sleep 
patterns. In the multivariate analysis, after adjustment for multiple possible confounding factors, the ODI 
_ 4% and ODI _ 6% remained significantly and independently associated with impaired performance on cognitive 
tests. However, diurnal cortisol levels were not different between groups (with or without CI), and they do not seem 
to mediate the link between SDB and cognitive performance. Addressing the relationship between SDB and cortisol 
levels, some previous studies (Edwards et al., 2014), but not all (Dadoun et al., 2007), have identified differences 
in cortisol between SDB patients and controls, or before and after continuous positive airway pressure treatment 
(Henley et al., 2009; Schmoller et al., 2009). 
A growing body of research reveals a consistent association between SDB and CI. SDB induces intermittent 
hypoxemia and recurrent arousals that are responsible for sudden surges of sympathetic nerve system activity and 
are associated with increased pulsatile cortisol release (Spath-Schwalbe et al., 1991). Increased cortisol levels have 
been independently associated with poor cognitive performances (Ouanes et al., 2017; Popp et al., 2015), and 
both SDB-related intermittent hypoxia and exposure to increased cortisol levels are thus potential mechanisms of 
the link between SDB and CI (Galanjauskas et al., 2017). 
Our results suggest that intermittent hypoxia is likely to be the main mechanism through which SDB is associated 
with CI. On the contrary, measures of salivary diurnal cortisol were not different between CI and subjects with 
normal cognition, and the results of Sobel’s test for mediation using the regressions between the AHI and the ODI 
indexes, and the CDR status and the cortisol measurements, were not significant. While Edwards KM et al., 
examining the associations between SDB, cognitive function, and cortisol levels, found that nighttime cortisol levels 
were a significant predictor of neurocognitive functioning (Edwards et al., 2014), our data suggest that diurnal 
cortisol is not a significant mediator of the link between SDB and cognitive performance in the elderly population. 
Sources of inconsistency between different reports in this area include differences in study design, data collection 
and measurements, sample sizes, and potential confounding factors (Tomfohr et al., 2012). However, whether 
increased cortisol related to SDB may significantly contribute to cognitive decline in older people (Popp et al., 2015) 
could also depend on the presence of Alzheimer’s disease pathology in brain regions particularly vulnerable to 
cortisol exposure such as the hippocampus. Our study has some limitations that have to be pointed out: only 
28.3% of thewhole cohort had a complete evaluation (cortisol profile, the cognitive assessment, and the PSG) and 
our study may be underpowered to detect subtle differences between groups; the evaluations were not carried out 
at the same time; cortisol measure was restricted to 1 day; we do not have measures of nocturnal cortisol levels; 
and our analyses are based on cross-sectional data, and do not allow drawing conclusions about cause-to-effect 
relationships. Despite these limitations,we foundthat participants fromthegeneral population aged _65 years with CI 
have more disrupted sleep but similar cortisol profile during the daytime. Intermittent hypoxia related to SDB seems 
to be the main factor associated with cognitive deficits, and daytime cortisol levels do not seem to play a mediating 
role between SDB and cognitive performance. 
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Annexes :  
 
Supplementary Figure e-1. Studied population. 
 
 
 
 
 
  
  
Supplementary Table e-1. Cognitive test performance of the studied population, according to CDR 
status. 
 
 CDR = 0 
(n=289) 
CDR > 0 
(n=291) 
p value 
Memory tasks 
(Grober and Buschke) 
   
Immediate recall 16.36±4.46 15.85±2.74 0.120 
Total free recall 33.82±4.87 26.23±6.91 <0.001 
Total cued recall 17.30±11.26 19.56±8.54 0.009 
Identification 15.96±0.50 15.93±0.43 0.549 
Recognition 45.61±8.21 44.85±9.04 0.322 
Delayed free recall 12.82±1.90 10.38±2.81 <0.001 
Delayed cued recall 4.60±4.31 5.73±3.57 0.001 
    
Other cognitive tasks     
Mini-Mental State Examination 28.91±3.03 28.45±2.30 0.201 
CERAD figures 10.52±1.01 10.42±1.14 0.307 
Semantic verbal fluency 31.72±8.24 27.94±7.80 <0.001 
Phonemic verbal fluency 22.73±7.65 19.23±7.63 <0.001 
Stroop dots condition 23.94±0.31 23.81±0.96 0.039 
Stroop words condition 23.96±0.22 23.92±0.60 0.303 
Stroop interference condition 23.30±1.80 23.10±1.80 0.193 
DO40 naming task 39.85±0.48 39.65±1.26 0.025 
 
CDR: Clinical Dementia Rating Scale. Mean ± SD. 
  
Supplementary Table e-2. Objective sleep characteristics according to CDR status. 
  
CDR = 0 
(n=289) 
CDR > 0 
(n=291) 
p value 
Total sleep time, min1 392.2 ± 72.8 380.9 ± 77.4 0.070 
Stage N1, min1 49.2 ± 28.7 55.7 ± 32.7 0.011 
Stage N1, %1 12.9 ± 8.5 15.1 ± 9.5 0.004 
Stage N2, min1 195.5 ± 60.3 190.4 ± 66.3 0.337 
Stage N2, %1 49.5 ± 11.8 49.6 ± 12.4 0.914 
Slow wave sleep (stage N3), min1 67.5 ± 32.6 61.0 ± 33.4 0.018 
Slow wave sleep (stage N3), %1 17.4 ± 8.5 16.2 ± 8.9 0.097 
REM sleep, min1 80.0 ± 31.0 73.7 ± 31.8 0.016 
REM sleep, %1 20.2 ± 6.7 19.1 ± 7.0 0.054 
Sleep onset latency, min2 12.7 [5.5-27.3] 14.3 [6.5-29.8] 0.300 
Sleep efficiency, %2 85.0 [72.7-84.4] 78.5 [70.0-85.7] 0.007 
Wake after sleep onset, min2 89.3 [55.0-141.6] 100.6 [68.3-148.0] 0.018 
REM latency, min2 78.0 [59.5-128.0] 79.7 [58.0-123.5] 0.779 
Number of stage shifts2 141 [109-172] 149 [115-190] 0.078 
Apnea/hypopnea index, n/h2 12.9 [7.2-24.5] 18.0 [7.8-35.5] <0.001 
Mean SaO2, %
2 93.6 [92.5-94.5] 93.5 [92.4-94.4] 0.325 
Lowest SaO2, % 
2 85 [82-88] 85 [80-87] 0.029 
Oxygen desaturation index ≥ 3%, 
n/h2 
13.5 [6.9-23.7] 17.1 [7.1-32.9] 0.007 
Oxygen desaturation index ≥ 4%, 
n/h2 
6.3 [2.3-13.2] 9.0 [3.2-20.2] 0.001 
Oxygen desaturation index ≥ 6%, 
n/h2 
1.1 [0.2-4.7] 2.2 [0.5-8.0] <0.001 
Arousal index, n/h2 22.4 [15.8-29.0] 23.3 [16.4-34.2] 0.102 
PLMS index, n/h2 10.8 [0.3-36.7] 13.4 [0.0-36.9] 0.848 
 
CDR: Clinical Dementia Rating Scale; REM : rapid eye movement sleep ; PLMS : periodic leg 
movements during sleep. 1 mean  ± standard deviation ; 2 percentile 50 [percentile 25-
percentile75]. 
  
Supplementary Table e-3. Association of polysomnographic variables with a CDR > 0, multivariate 
analysis. 
  Odds ratio*  [95% Conf.Interval] p value 
Total sleep time, min 1.00 0.97 - 1.02 0.884 
Stage N1, min 1.04 0.97 - 1.10 0.246 
Stage N2, min 0.99 0.96 - 1.02 0.576 
Slow wave sleep (stage N3), min 1.01 0.95 - 1.07 0.792 
REM sleep, min 0.98 0.92 - 1.04 0.548 
Sleep onset latency, min 0.97 0.91 - 1.04 0.466 
Sleep efficiency, % 0.97 0.82 - 1.13 0.675 
Wake after sleep onset, min 1.00 0.97 - 1.03 0.832 
REM latency, min 0.99 0.96 - 1.01 0.309 
Number of stage shifts 1.01 0.97 - 1.04 0.720 
Apnea/hypopnea index, n/h 1.15 1.00 - 1.31 0.043 
Mean SaO2, % 0.73 0.22 -  2.38 0.602 
Lowest SaO2, %  0.79 0.56 - 1.12 0.184 
Oxygen desaturation index ≥ 3%, n/h 1.09 0.96 - 1.22 0.173 
Oxygen desaturation index ≥ 4%, n/h 1.17 1.01 - 1.36 0.033 
Oxygen desaturation index ≥ 6%, n/h 1.33 1.03 - 1.72 0.029 
Arousal index, n/h 1.00 0.86 - 1.16 0.993 
PLMS index, n/h  1.00 0.95 - 1.06 0.885 
 
*Odds-ratio for an increase of 10-units. Multivariate logistic regression model adjusted for each 
variable for age, sex, hypertension, diabetes, metabolic syndrome, depression, lifetime depression, 
BMI, alcohol and tobacco consumption, drugs influencing sleep and level of education. CDR: Clinical 
Dementia Rating Scale; REM : rapid eye movement sleep ; AHI : apnea/hypopnea index; PLMS : 
periodic legs movements during sleep. 
 
